| Issue Date | Title | Author(s) |
| 2017-11-29 | DBNorm: Normalizing high-density oligonucleotide microarray data based on distributions | Meng, Q; Catchpoole, D; Skillicorn, D; Kennedy, PJ |
| 2019-06 | Risk factors for symptomatic venous thromboembolism during therapy for childhood acute lymphoblastic leukemia. | Mateos, MK; Trahair, TN; Mayoh, C; Barbaro, PM; Sutton, R; Revesz, T; Barbaric, D; Giles, JE; Alvaro, F; Mechinaud, F; Catchpoole, D; Kotecha, RS; Dalla-Pozza, L; Quinn, MCJ; MacGregor, S; Chenevix-Trench, G; Marshall, GM |
| 2018-12-10 | Lymphocyte-Specific Chromatin Accessibility Pre-determines Glucocorticoid Resistance in Acute Lymphoblastic Leukemia | Jing, D; Huang, Y; Liu, X; Sia, KCS; Zhang, JC; Tai, X; Wang, M; Toscan, CE; McCalmont, H; Evans, K; Mayoh, C; Poulos, RC; Span, M; Mi, J; Zhang, C; Wong, JWH; Beck, D; Pimanda, JE; Lock, RB |
| 2022-03-01 | Methotrexate-related central neurotoxicity: clinical characteristics, risk factors and genome-wide association study in children treated for acute lymphoblastic leukemia. | Mateos, MK; Marshall, GM; Barbaro, PM; Quinn, MCJ; George, C; Mayoh, C; Sutton, R; Revesz, T; Giles, JE; Barbaric, D; Alvaro, F; Mechinaud, F; Catchpoole, D; Lawson, JA; Chenevix-Trench, G; MacGregor, S; Kotecha, RS; Dalla-Pozza, L; Trahair, TN |
| 2014 | Confirmation of childhood acute lymphoblastic leukemia variants, ARID5B and IKZF1, and interaction with parental environmental exposures. | Evans, T-J; Milne, E; Anderson, D; de Klerk, NH; Jamieson, SE; Talseth-Palmer, BA; Bowden, NA; Holliday, EG; Rudant, J; Orsi, L; Richardson, E; Lavis, L; Catchpoole, D; Attia, JR; Armstrong, BK; Clavel, J; Scott, RJ |
| 2015-04 | The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias. | Andersson, AK; Ma, J; Wang, J; Chen, X; Gedman, AL; Dang, J; Nakitandwe, J; Holmfeldt, L; Parker, M; Easton, J; Huether, R; Kriwacki, R; Rusch, M; Wu, G; Li, Y; Mulder, H; Raimondi, S; Pounds, S; Kang, G; Shi, L; Becksfort, J; Gupta, P; Payne-Turner, D; Vadodaria, B; Boggs, K; Yergeau, D; Manne, J; Song, G; Edmonson, M; Nagahawatte, P; Wei, L; Cheng, C; Pei, D; Sutton, R; Venn, NC; Chetcuti, A; Rush, A; Catchpoole, D; Heldrup, J; Fioretos, T; Lu, C; Ding, L; Pui, C-H; Shurtleff, S; Mullighan, CG; Mardis, ER; Wilson, RK; Gruber, TA; Zhang, J; Downing, JR; St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project, |
| 2020-06 | Reversal of glucocorticoid resistance in paediatric acute lymphoblastic leukaemia is dependent on restoring BIM expression. | Toscan, CE; Jing, D; Mayoh, C; Lock, RB |
| 2016-09-13 | A single nucleotide polymorphism genotyping platform for the authentication of patient derived xenografts. | El-Hoss, J; Jing, D; Evans, K; Toscan, C; Xie, J; Lee, H; Taylor, RA; Lawrence, MG; Risbridger, GP; MacKenzie, KL; Sutton, R; Lock, RB |
| 2022-09 | ALNett: A cluster layer deep convolutional neural network for acute lymphoblastic leukemia classification. | Jawahar, M; H, S; L, JA; Gandomi, AH |
| 2022-01 | PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by NSD2 Mutation in Pediatric Acute Lymphoblastic Leukemia. | Li, J; Hlavka-Zhang, J; Shrimp, JH; Piper, C; Dupéré-Richér, D; Roth, JS; Jing, D; Casellas Román, HL; Troche, C; Swaroop, A; Kulis, M; Oyer, JA; Will, CM; Shen, M; Riva, A; Bennett, RL; Ferrando, AA; Hall, MD; Lock, RB; Licht, JD |
